Medical device maker Covidien has lost a bid to have the applicant in a product liability class action over allegedly defective pelvic mesh front $300,000 as security for its legal costs in the event it wins the case.
Class actions and litigation funding reform: The views of class action practitioners
A sense of frustration with current uncertainty in the caselaw and inconsistency in the approaches of judges was a prominent theme that emerged from personal interviews with 30 experienced class action practitioners conducted over two months by Dr Peter Cashman and Amelia Simpson of the University of New South Wales.
No relief: AFT appeals Reckitt-Benckiser win over Maxigesic ads
The maker of pain killer Maxigesic is taking its long-running battle with Nuromol manufacturer Reckitt Benckiser to an appeals court after a recent ruling that its advertising misled consumers by claiming Maxigesic provided better, faster and more effective pain relief than paracetamol or ibuprofen.